2022
DOI: 10.1016/s2352-3026(22)00074-6
|View full text |Cite
|
Sign up to set email alerts
|

Prehospital blood transfusion: who benefits?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 9 publications
0
3
0
1
Order By: Relevance
“…The volume and infusion speed of fluids administered prior to diagnostics is reduced, aiming for a period of permissive hypotension ( 43 ). Furthermore and following the rationale of prompt haemostatic resuscitation (administration of blood products), transfusion protocols during the transfer of bleeding trauma patients to the hospital have been introduced ( 44 , 45 ).…”
Section: Key Elements At the Prehospital Phasementioning
confidence: 99%
“…The volume and infusion speed of fluids administered prior to diagnostics is reduced, aiming for a period of permissive hypotension ( 43 ). Furthermore and following the rationale of prompt haemostatic resuscitation (administration of blood products), transfusion protocols during the transfer of bleeding trauma patients to the hospital have been introduced ( 44 , 45 ).…”
Section: Key Elements At the Prehospital Phasementioning
confidence: 99%
“…Bei der Fallzahlkalkulation der RePhill-Studie fällt die antizipierte Inzidenz des primären Endpunkts von 10 % in der Interventionsgruppe bzw. 20 % in der Kontrollgruppe auf: Dies entspräche einer relativen Risikoreduktion von 50 %, was bei einer Zielgröße wie der Mortalität (die ohnehin zahlreichen Einflussfaktoren unterliegt) als sehr ambitioniert erscheint [ 34 ]. Auch der zusammengesetzte Endpunkt aus einem klinisch relevanten Parameter und einem Surrogatparameter unklarer Signifikanz kann kritisch hinterfragt werden [ 34 ].…”
Section: Prähospitale Transfusion Von Blut Und Blutersatzprodukten – ...unclassified
“…alloimmunization), and resource requirements, questions remain and debate continues. 2,5,6 Issues surrounding CivPHT are being actively addressed by ongoing randomized trials such as the Type O Whole Blood and Assessment of Age During Prehospital Resuscitation (TOWAR, clini caltr ials. gov 04684719).…”
Section: Introductionmentioning
confidence: 99%
“…With regard to CivPHT patient eligibility, components (and ratios), complications (e.g. alloimmunization), and resource requirements, questions remain and debate continues 2,5,6 …”
Section: Introductionmentioning
confidence: 99%